AlphaCrest Capital Management LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 190 filers reported holding HERON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
AlphaCrest Capital Management LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$244,000
-21.3%
26,755
+39.9%
0.01%
-47.1%
Q1 2021$310,000
+42.9%
19,123
+86.8%
0.02%
-5.6%
Q4 2020$217,000
+17.9%
10,237
-18.1%
0.02%
-41.9%
Q2 2020$184,000
-52.3%
12,494
-62.0%
0.03%
-34.0%
Q1 2020$386,000
+17.7%
32,881
+135.3%
0.05%
+74.1%
Q4 2019$328,00013,9720.03%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 8,648,252$238,692,00035.08%
Broadfin Capital, LLC 1,581,416$43,647,0006.80%
Tavio Capital LLC 351,729$9,708,0004.58%
Mesirow Financial Investment Management, Inc. 33,389$922,0003.88%
Rubric Capital Management LP 1,510,008$41,676,0003.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,666,229$45,988,0003.63%
First Light Asset Management, LLC 473,275$13,062,0002.87%
Asymmetry Capital Management, L.P. 77,346$2,135,0002.67%
Copernicus Capital Management, LLC 108,000$2,981,0002.38%
BRIDGER MANAGEMENT, LLC 1,277,560$35,261,0002.14%
View complete list of HERON THERAPEUTICS INC shareholders